Skip to main content
logo
Amicogen, Inc. (KOSDAQ:092040)
South Korea flag South Korea · Delayed Price · Currency is KRW
897.00
+9.00 (1.01%)
Sep 22, 2026, 3:30 PM KST

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Special Enzymes, New Bio Materials, Biopharmaceutical Material, Health and Beauty
55.18B48.67B47.13B53.38B69.62B
Consolidation Adjustment
-15.50B-11.65B-8.20B-11.58B-17.11B
Treatment for Incurable and Rare Diseases
--22.93M10.09M-
Raw Drug Substance
120.22B107.27B85.93B74.05B62.67B
Total
159.90B144.30B124.88B115.86B115.18B

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
South Korea
27.04B28.21B95.65B83.87B72.32B
Overseas
132.87B116.09B29.23B31.98B42.86B
Total
159.90B144.30B124.88B115.86B115.18B